VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (InMed or the Company) (Nasdaq: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced that a peer-reviewed scientific article entitled Cannabinol Modulates Neuroprotection and Intraocular Pressure: A Potential Multi-Target Therapeutic Intervention for Glaucoma, has been published in Biochimica et Biophysical Acta (BBA - Molecular Basis of Disease), a leading international journal focused on biochemistry and molecular genetics of disease processes and models of human disease in the area of aging, cancer, metabolic-, neurological-, and immunological-based diseases.
The peer-reviewed article highlights research evaluating the use of cannabinol, or CBN, as a potential treatment option for glaucoma. Several studies were conducted to evaluate the survival of retinal ganglion cells, modulation of intraocular pressure and its effects on extracellular matrix proteins using in vitro and in vivo glaucoma models.
These studies resulted in two key findings: first, CBN may promote neuroprotection of cells in the retina that are responsible for vision; and second, CBN may normalize intraocular pressure by attenuating changes in the extracellular matrix proteins. The article also reports on the comparison of CBN with other cannabinoids, including cannabidiol (CBD) and tetrahydrocannabinol (THC), with results indicating that CBN has a stronger effect and broader neuroprotective therapeutic range. These observations elucidate the therapeutic potential for CBN in the treatment of glaucoma.
Having this research peer-reviewed and published in such a reputable journal is a significant milestone for InMeds glaucoma development program. This provides important external validation for the scientific community as the program advances towards human studies, said InMeds scientific advisor, Dr. Mauro Maccarrone, Professor and Chair of Biochemistry at the Department of Biotechnological and Applied Clinical Sciences, University of LAquila, Italy. We believe InMeds INM-088 program has significant implications for neuroprotection within the glaucoma space and may lead to a potential new treatment for millions of people suffering from this condition worldwide.
Corresponding author Professor Ujendra Kumar, Faculty of Pharmaceuticals, The University of British Columbia, added; The observations in this study indicate the therapeutic potential for the use of CBN in the treatment of glaucoma. Not only does the data suggest a reduction in ocular pressure but also proactive neuroprotection in the retina, both of which are integral to the treatment of glaucoma. This publication is further evidence to suggest rare cannabinoids have therapeutic potential to treat various diseases.
The journal article can be accessed here: https://doi.org/10.1016/j.bbadis.2021.166325
About Glaucoma: Glaucoma is a group of eye diseases which result in damage to the optic nerve due to high intraocular pressure (IOP) of the eye from fluid build-up. According to the American Academy of Ophthalmology, glaucoma is the leading cause of blindness in adults aged 60 and older. It is estimated that 76 million people worldwide have glaucoma. There is a major unmet medical need for new glaucoma treatments that provide neuroprotection of retinal ganglion cells. Current treatments work to reduce intraocular pressure but do not provide direct neuroprotection in the retina.
About CBN: Cannabinol (CBN) is a non-intoxicating rare cannabinoid. It is one of the more than 140 cannabinoid compounds present in the Cannabis plant. CBN is also the active pharmaceutical ingredient in InMeds lead program, INM-755 cannabinol cream, which is currently undergoing a Phase 2 Clinical Trial in the treatment ofEpidermolysis Bullosa (EB). In several preclinical safety pharmacology and toxicology studies using CBN at high doses, no adverse events were seen on central nervous system (CNS) function in a rigorous evaluation of 108 CNS measurements.
Learn about InMeds INM-088, a CBN topical formulation for the treatment of glaucoma: https://www.inmedpharma.com/pharmaceutical/inm-088-for-glaucoma/
Learn more about cannabinol: https://www.inmedpharma.com/learn/what-is-cannabinol/
About InMed: InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids. Together with its subsidiary, BayMedica LLC, the Company has unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visitwww.inmedpharma.com and http://www.baymedica.com.
Investor Contact: Colin ClancySenior Director, Investor RelationsT: +1 604 416 0999E: cclancy@inmedpharma.com
Edison Group:Joe Green/Laine YonkerT: +1.646.653.7030/+1.646.653.7035E: jgreen@edisongroup.com / lyonker@edisongroup.com
Cautionary Note Regarding Forward-Looking Information:
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws. Forward-looking information is based on management's current expectations and beliefs and is subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking information in this news release includes statements about: a topical eye drop formulation under development for the treatment of glaucoma; CBN promoting neuroprotection of the eye and normalizing intraocular pressure and the potential to treat millions suffering from glaucoma; the potential for rare cannabinoids to treat various diseases; being a global leader in the manufacturing and development of rare cannabinoids; and delivering new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs.
With respect to the forward-looking information contained in this news release, InMed has made numerous assumptions. While InMed considers these assumptions to be reasonable, these assumptions are inherently subject to significant business, economic, competitive, market and social uncertainties and contingencies.
Additionally, there are known and unknown risk factors which could cause InMed's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. A complete discussion of the risks and uncertainties facing InMeds stand-alone business is disclosed in InMeds Annual Report on Form 10-K and other filings with the Security and Exchange Commission on http://www.sec.gov.
All forward-looking information herein is qualified in its entirety by this cautionary statement, and InMed disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.
Continued here:
InMed Pharmaceuticals Announces Publication of Peer-Reviewed Article on the Use of CBN as a Potential Treatment for Glaucoma - GlobeNewswire
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit [Last Updated On: April 26th, 2012] [Originally Added On: April 26th, 2012]
- Protein could be key for drugs that promote bone growth [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- Study sheds light on genetic 'clock' in embryonic cells [Last Updated On: November 14th, 2012] [Originally Added On: November 14th, 2012]
- Study involving twin sisters provides clues for battling aggressive cancers [Last Updated On: February 9th, 2014] [Originally Added On: February 9th, 2014]
- Clues for battling aggressive cancers from twin sisters study [Last Updated On: February 11th, 2014] [Originally Added On: February 11th, 2014]
- Genetic cause found for premature ovarian failure [Last Updated On: March 6th, 2014] [Originally Added On: March 6th, 2014]
- Rutgers' Human Genetics Institute Wins $19 Million Federal Contract [Last Updated On: May 15th, 2014] [Originally Added On: May 15th, 2014]
- Elsevier Publishes Four New Books in Microbiology Portfolio [Last Updated On: November 13th, 2014] [Originally Added On: November 13th, 2014]
- Disease, Evolution, Neurology, and Drugs: Fruit Fly Research Continues to Teach Us About Human Biology [Last Updated On: February 28th, 2015] [Originally Added On: February 28th, 2015]
- "Big Brain" Gene Allowed for Evolutionary Expansion of Human Neocortex [Last Updated On: March 8th, 2015] [Originally Added On: March 8th, 2015]
- Director Molecular Genetics jobs in Rtp at LabCorp [Last Updated On: June 1st, 2015] [Originally Added On: June 1st, 2015]
- Molecular Genetics definition of Molecular Genetics in the ... [Last Updated On: June 4th, 2015] [Originally Added On: June 4th, 2015]
- molecular and human genetics | Momentum - The Baylor ... [Last Updated On: June 19th, 2015] [Originally Added On: June 19th, 2015]
- Molecular evolution - Wikipedia, the free encyclopedia [Last Updated On: July 16th, 2015] [Originally Added On: July 16th, 2015]
- The Rockefeller University Laboratory of Molecular Genetics [Last Updated On: July 21st, 2015] [Originally Added On: July 21st, 2015]
- Microbiology & Molecular Genetics - Rutgers New Jersey ... [Last Updated On: September 5th, 2015] [Originally Added On: September 5th, 2015]
- Clinical Genetics Congress | Clinical Genetics 2016 ... [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- Molecular genetics - Wikipedia, the free encyclopedia [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- Molecular Genetics - DNA, RNA, & Protein [Last Updated On: October 20th, 2016] [Originally Added On: October 20th, 2016]
- MCW: Microbiology and Molecular Genetics Department [Last Updated On: October 21st, 2016] [Originally Added On: October 21st, 2016]
- Newcastle Hospitals - Molecular Genetics [Last Updated On: October 21st, 2016] [Originally Added On: October 21st, 2016]
- Molecular evolution - Wikipedia [Last Updated On: October 23rd, 2016] [Originally Added On: October 23rd, 2016]
- Molecular Genetics (Stanford Encyclopedia of Philosophy) [Last Updated On: October 30th, 2016] [Originally Added On: October 30th, 2016]
- Molecular Genetics - mmrl.edu [Last Updated On: November 12th, 2016] [Originally Added On: November 12th, 2016]
- Molecular biology - Wikipedia [Last Updated On: November 12th, 2016] [Originally Added On: November 12th, 2016]
- Human Molecular Genetics - amazon.com [Last Updated On: November 12th, 2016] [Originally Added On: November 12th, 2016]
- Molecular Genetics Service - Great Ormond Street Hospital ... [Last Updated On: November 16th, 2016] [Originally Added On: November 16th, 2016]
- The Passions of Nazneen Rahman - San Francisco Classical Voice [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Genetic Testing for the Healthy - Harvard Medical School (registration) [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Fundraising page set up in memory of Nottingham's Maid Marian - Nottingham Post [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Dogs have their day at conference - Otago Daily Times [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- GGC Graduates Two from Medical Genetics Training Program - Index-Journal [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Irvine-based CombiMatrix in $33 million merger deal with Bay Area genetics firm - OCRegister [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- First of 10 expected BJC Investigators named - Washington University School of Medicine in St. Louis [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- Madhuri Hegde, PhD is Elected to the Board of the ACMG Foundation for Genetic and Genomic Medicine - Markets Insider [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- Getting the word out: Seminar, walk put spotlight on Sickle Cell disease - Dothan Eagle [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
- Out of a fish gut study, researchers open new doors in intestinal health - Durham Herald Sun [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
- Gene-Silencing Finding May Lead to Better Understanding of Some ... - Genetic Engineering & Biotechnology News [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
- Molecular Genetics and Genomics Program - Wake Forest ... [Last Updated On: October 1st, 2017] [Originally Added On: October 1st, 2017]
- Genetics and Molecular Biology | Peer Reviewed Journal [Last Updated On: June 30th, 2018] [Originally Added On: June 30th, 2018]
- Leeds Genetics Laboratory - Leeds Teaching Hospitals NHS Trust [Last Updated On: July 17th, 2018] [Originally Added On: July 17th, 2018]
- Genetics and Molecular Biology Research - iMedPub [Last Updated On: August 2nd, 2018] [Originally Added On: August 2nd, 2018]
- Molecular Genetics | ARUP Laboratories [Last Updated On: August 7th, 2018] [Originally Added On: August 7th, 2018]
- Molecular Genetics - The Ohio State University [Last Updated On: August 21st, 2018] [Originally Added On: August 21st, 2018]
- Peer Reviewed Genetics and Molecular Biology Journals ... [Last Updated On: September 5th, 2018] [Originally Added On: September 5th, 2018]
- Department of Microbiology and Molecular Genetics [Last Updated On: October 7th, 2018] [Originally Added On: October 7th, 2018]
- Molecular Genetics Jobs, Employment | Indeed.com [Last Updated On: October 10th, 2018] [Originally Added On: October 10th, 2018]
- Genomic Career: Molecular Geneticist ($35,620-$101,030) [Last Updated On: October 10th, 2018] [Originally Added On: October 10th, 2018]
- Molecular Genetics, Biochemistry & Microbiology [Last Updated On: October 10th, 2018] [Originally Added On: October 10th, 2018]
- Molecular Genetics | Department of Pediatrics [Last Updated On: December 1st, 2018] [Originally Added On: December 1st, 2018]
- Graduate Molecular Genetics - University of Toronto [Last Updated On: January 25th, 2019] [Originally Added On: January 25th, 2019]
- Molecular Genetics - OCME - nyc.gov [Last Updated On: February 19th, 2019] [Originally Added On: February 19th, 2019]
- Molecular Genetics - University of Toronto [Last Updated On: March 6th, 2019] [Originally Added On: March 6th, 2019]
- Department of Microbiology, Immunology and Molecular Genetics [Last Updated On: March 13th, 2019] [Originally Added On: March 13th, 2019]
- Molecular Genetics and Cell Biology [Last Updated On: May 4th, 2019] [Originally Added On: May 4th, 2019]
- Molecular Reproduction, Development and Genetics at IISc [Last Updated On: May 18th, 2019] [Originally Added On: May 18th, 2019]
- Molecular genetics | biology | Britannica.com [Last Updated On: September 7th, 2019] [Originally Added On: September 7th, 2019]
- BCH N of 1 Trial Yields Approved Therapy for Single Rare Disease Patient - Clinical OMICs News [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- 5 habits of highly successful entrepreneurs revealed - GrowthBusiness.co.uk [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- Leading by example: how AquaBounty, Oxford Biomedica, and Berkeley Lights have successfully brought products to market - SynBioBeta [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- Blue Devil of the Week: Searching for Answers in the Genetic Code - Duke Today [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- New Viruses Found in Farmed and Wild Salmon - Hakai Magazine [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- Veterinary Molecular Diagnostics Market to Reach at a CAGR of 8.48% by 2026 With NEOGEN CORPORATION , Thermo Fisher Scientific, Inc., Virbac, General... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Quantabio to Showcase Industry's Fastest qPCR-based NGS Library Quantification Kit and HiFi PCR Mix at American Society of Human Genetics Annual... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Top Researchers to Present Discoveries Made Possible by Bionanos Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual Meeting - Yahoo... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Bionano Genomics Announces Adoption of Its Saphyr System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Racial Disparities In NIH R01 Funding May Be Partly Caused By Topic Choice : Shots - Health News - NPR [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Denison presents: 'Christianity, Race, and the Haunting of the Biomedical Sciences' - The Newark Advocate [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- This image shows the aftermath of two galaxies colliding - CTV News [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Meet The Cast of Charmed Season 2 - TVOvermind [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Inherited Learning? It Happens, but How Is Uncertain - Quanta Magazine [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Where do Canada's federal parties stand on research funding? - Varsity [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- The double bind faced by black research applicants - University World News [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Excessive Brain Activity Linked to Shorter Life Span - PsychCentral.com [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board - PRNewswire [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Lupus Study Illustrates the Importance of Diversity in Genetic Research - Nature World News [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- Interpace to Present Data at the ATA Annual Meeting - GlobeNewswire [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- Pacific subspecies of fin whales has been revealed by new genetic study - Oceanographic - Oceanographic Magazine [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- Genetic Study: Shared Molecular Pathway Might Influence Susceptibility to Lack of Oxygen Caused by Sleep-disordered Breathing and Other Lung Illnesses... [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- ERT to Treat Pompe May Work Better in Combo with Blood Pressure Medication, Study Says - Pompe Disease News [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]